EIGR

Eiger BioPharmaceuticals, Inc.
EIGR

Overview Fund Activity
Delisted

EIGR was delisted on the 10th of April, 2024.

Back to rankings

45 hedge funds and large institutions have $123M invested in Eiger BioPharmaceuticals, Inc. in 2014 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 14 increasing their positions, 10 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
45
Holders Change
+5
Holders Change %
+12.5%
% of All Funds
1.31%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
14
Increased
14
Reduced
10
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
EAM
1
Eagle Asset Management
Florida
$17M
2
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$10.5M
3
BBA
3
Baker Bros. Advisors
New York
$3.92M
4
Axa
4
Axa
France
$3.07M
5
MAA
5
Managed Account Advisors
New Jersey
$2.4M

Top Sellers

1
Northern Trust
1
Northern Trust
Illinois
$162K
2
PP
2
Paloma Partners
Connecticut
$0
3
Bank of America
3
Bank of America
North Carolina
$1K
4
COPPSERS
4
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$0
5
LP
5
LMR Partners
United Kingdom
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Goldman Sachs
51
Goldman Sachs
New York
– -$219K -30 Closed
LP
52
LMR Partners
United Kingdom
– -$219K -30 Closed
Millennium Management
53
Millennium Management
New York
– -$195K -27 Closed
BA
54
BlackRock Advisors
Delaware
– -$85K -12 Closed
Morgan Stanley
55
Morgan Stanley
New York
– -$38K -5 Closed
Royal Bank of Canada
56
Royal Bank of Canada
Ontario, Canada
– -$2K – –
Bank of Montreal
57
Bank of Montreal
Ontario, Canada
– -$3K – –
1 2
3